Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Overview
Affiliations
Continuous hydroxylation of the HIF-1 transcription factor alpha subunit by oxygen and 2-oxoglutarate-dependent dioxygenases promotes decay of this protein and thus prevents the transcriptional activation of many genes involved in energy metabolism, angiogenesis, cell survival, and matrix modification. Hypoxia blocks HIF-1alpha hydroxylation and thus activates HIF-1alpha-mediated gene expression. Several nonhypoxic stimuli can also activate HIF-1, although the mechanisms involved are not well known. Here we show that the glucose metabolites pyruvate and oxaloacetate inactivate HIF-1alpha decay in a manner selectively reversible by ascorbate, cysteine, histidine, and ferrous iron but not by 2-oxoglutarate or oxygen. Pyruvate and oxaloacetate bind to the 2-oxoglutarate site of HIF-1alpha prolyl hydroxylases, but their effects on HIF-1 are not mimicked by other Krebs cycle intermediates, including succinate and fumarate. We show that inactivation of HIF-1 hydroxylation by glucose-derived 2-oxoacids underlies the prominent basal HIF-1 activity commonly seen in many highly glycolytic cancer cells. Since HIF-1 itself promotes glycolytic metabolism, enhancement of HIF-1 by glucose metabolites may constitute a novel feed-forward signaling mechanism involved in malignant progression.
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment.
Yang H, Li J, Niu Y, Zhou T, Zhang P, Liu Y Front Immunol. 2025; 16:1494788.
PMID: 40028341 PMC: 11868052. DOI: 10.3389/fimmu.2025.1494788.
Lactate and lactylation in cancer.
Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y Signal Transduct Target Ther. 2025; 10(1):38.
PMID: 39934144 PMC: 11814237. DOI: 10.1038/s41392-024-02082-x.
Hypoxia signaling in the adipose tissue.
Huynh P, Wang F, An Y J Mol Cell Biol. 2024; 16(8).
PMID: 39363240 PMC: 11892559. DOI: 10.1093/jmcb/mjae039.
Wang J, Kunikata H, Yasuda M, Himori N, Nitta F, Nakazawa T Ophthalmol Sci. 2024; 4(6):100550.
PMID: 39100756 PMC: 11293568. DOI: 10.1016/j.xops.2024.100550.
Xu B, Liu Y, Li N, Geng Q Front Immunol. 2024; 15:1395786.
PMID: 38835758 PMC: 11148263. DOI: 10.3389/fimmu.2024.1395786.